Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review)
Bordin, D.S.; Masharova, A.A.; Lazebnik, L.B.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 2008(4): 36-38
2008
ISSN/ISBN: 1682-8658 PMID: 19145902 Document Number: 618849
Document emailed within 1 workday
Related Documents
Isakova, V.A. 2006: New paradigm of the GERB and long-term therapy with proton pump inhibitors Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 53-58Mazure, P.A. 1996: Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA) Acta Gastroenterologica Latinoamericana 26(4): 263-265
Sachs, G.; Shin, J.M.; Pratha, V.; Hogan, D. 2003: Synthesis or rupture: duration of acid inhibition by proton pump inhibitors Drugs of Today 39 Suppl A: 11-14
Klotz, U. 2006: Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem International Journal of Clinical Pharmacology and Therapeutics 44(7): 297-302
Orel, R.; Murch, S.; Amil Dias, J.; Vandenplas, Y.; Homan, M. 2016: Eosinophilic esophagitis that develops during therapy with proton pump inhibitors : case series and possible mechanisms Acta Gastro-Enterologica Belgica 79(2): 245-250
Orlando, R.C. 1996: Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective American Journal of Gastroenterology 91(9): 1692-1696
Trenk, D. 2009: Proton pump inhibitors for prevention of bleeding episodes in cardiac patients with dual antiplatelet therapy - between Scylla and Charybdis? International Journal of Clinical Pharmacology and Therapeutics 47(1): 1-10
Eissele, R.; Arnold, R. 1993: Risk for developing tumors in therapy with the proton pump inhibitor omeprazole Versicherungsmedizin 45(4): 126-129
Lundell, L. 2004: Are the proton pump inhibitors all the same? Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 126-128
Numans, M.E.; Lau, J.; de Wit, N.J.; Bonis, P.A. 2004: Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics Nederlands Tijdschrift Voor Geneeskunde 148(39): 1924-1928
Bossuyt, P.M.M. 2005: Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics Nederlands Tijdschrift Voor Geneeskunde 149(6): 321
Saad, F.; Finelli, A.; Dranitsaris, G.; Goldenberg, L.; Bagnell, S.; Gleave, M.; Fleshner, N. 2006: Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature Canadian Journal of Urology 13 Suppl. 3: 16-24
Jewett, M.; Rendon, R.; Dranitsaris, G.; Drachenberg, D.; Tanguay, S.; Donnelly, B.; Fleshner, N. 2006: Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature Canadian Journal of Urology 13 Suppl. 3: 54-61
Creutzfeldt, W. 1994: Are proton pump inhibitors safe? Der Internist 35(12): 1137-1146
Ječmenová, M.ét.; Kroupa, R. 2016: Proton pump inhibitors and their effect on the bone Vnitrni Lekarstvi 62(2): 139-146
Grau Amorós, J. 2000: Erectile dysfunction and proton pump inhibitors Medicina Clinica 114(12): 478
Doweck, J. 2009: Adverse effects of proton pump inhibitors Acta Gastroenterologica Latinoamericana 39(3): 219-222
Herszényi, L.; Tulassay, Z. 2001: Comparative study of proton pump inhibitors Orvosi Hetilap 142(36): 1953-1961
Reinberg, O. 2015: Proton pump inhibitors (PPI): may be not as harmless as believed Revue Medicale Suisse 11(485): 1665-1671
Reinberg, O. 2016: Proton pump inhibitors: not as harmless as believed La Revue du Praticien 66(4): 358-360